Suppr超能文献

表面活性蛋白A通过与表面活性蛋白D不同的机制下调表皮生长因子受体。

Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.

作者信息

Hasegawa Yoshihiro, Takahashi Motoko, Ariki Shigeru, Saito Atsushi, Uehara Yasuaki, Takamiya Rina, Kuronuma Koji, Chiba Hirofumi, Sakuma Yuji, Takahashi Hiroki, Kuroki Yoshio

机构信息

From the Departments of Biochemistry,

Respiratory Medicine and Allergology, and.

出版信息

J Biol Chem. 2017 Nov 10;292(45):18565-18576. doi: 10.1074/jbc.M117.800771. Epub 2017 Sep 27.

Abstract

We recently reported that the lectin surfactant protein D (SP-D) suppresses epidermal growth factor receptor (EGFR) signaling by interfering with ligand binding to EGFR through an interaction between the carbohydrate-recognition domain (CRD) of SP-D and -glycans of EGFR. Here, we report that surfactant protein A (SP-A) also suppresses EGF signaling in A549 human lung adenocarcinoma cells and in CHOK1 cells stably expressing human EGFR and that SP-A inhibits the proliferation and motility of the A549 cells. Results with I-EGF indicated that SP-A interferes with EGF binding to EGFR, and a ligand blot analysis suggested that SP-A binds EGFR in A549 cells. We also found that SP-A directly binds the recombinant extracellular domain of EGFR (soluble EGFR or sEGFR), and this binding, unlike that of SP-D, was not blocked by EDTA, excess mannose, or peptide:-glycosidase F treatment. We prepared a collagenase-resistant fragment (CRF) of SP-A, consisting of CRD plus the neck domain of SP-A, and observed that CRF directly binds sEGFR but does not suppress EGF-induced phosphorylation of EGFR in or proliferation of A549 cells. These results indicated that SP-A binds EGFR and down-regulates EGF signaling by inhibiting ligand binding to EGFR as well as SP-D. However, unlike for SP-D, SP-A lectin activity and EGFR -glycans were not involved in the interaction between SP-A and EGFR. Furthermore, our results suggested that oligomerization of SP-A is necessary to suppress the effects of SP-A on EGF signaling.

摘要

我们最近报道,凝集素表面活性蛋白D(SP-D)通过SP-D的碳水化合物识别结构域(CRD)与表皮生长因子受体(EGFR)的O-聚糖之间的相互作用,干扰配体与EGFR的结合,从而抑制EGFR信号传导。在此,我们报道表面活性蛋白A(SP-A)也能抑制A549人肺腺癌细胞和稳定表达人EGFR的CHO-K1细胞中的表皮生长因子(EGF)信号传导,并且SP-A能抑制A549细胞的增殖和运动。用碘标记的EGF(I-EGF)进行的实验结果表明,SP-A干扰EGF与EGFR的结合,配体印迹分析表明SP-A在A549细胞中与EGFR结合。我们还发现,SP-A直接结合EGFR的重组胞外结构域(可溶性EGFR或sEGFR),与SP-D不同的是,这种结合不受EDTA、过量甘露糖或肽:N-糖苷酶F处理的阻断。我们制备了SP-A的抗胶原酶片段(CRF),其由CRD加上SP-A的颈部结构域组成,并观察到CRF直接结合sEGFR,但不抑制EGF诱导的A549细胞中EGFR的磷酸化或增殖。这些结果表明,SP-A与EGFR结合,并通过抑制配体与EGFR的结合以及SP-D来下调EGF信号传导。然而,与SP-D不同的是,SP-A的凝集素活性和EGFR的O-聚糖不参与SP-A与EGFR之间的相互作用。此外,我们的结果表明,SP-A的寡聚化对于抑制SP-A对EGF信号传导的作用是必要的。

相似文献

1
Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.
J Biol Chem. 2017 Nov 10;292(45):18565-18576. doi: 10.1074/jbc.M117.800771. Epub 2017 Sep 27.
2
Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.
Oncogene. 2015 Feb 12;34(7):838-45. doi: 10.1038/onc.2014.20. Epub 2014 Mar 10.
4
Differential Ligand Binding Specificities of the Pulmonary Collectins Are Determined by the Conformational Freedom of a Surface Loop.
Biochemistry. 2017 Aug 8;56(31):4095-4105. doi: 10.1021/acs.biochem.6b01313. Epub 2017 Jul 31.
5
Neither SP-A nor NH2-terminal domains of SP-A can substitute for SP-D in regulation of alveolar homeostasis.
Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L181-90. doi: 10.1152/ajplung.00015.2006. Epub 2006 Feb 24.
6
Expression of epidermal growth factor and surfactant proteins during postnatal and compensatory lung growth.
Am J Physiol Lung Cell Mol Physiol. 2002 Nov;283(5):L981-90. doi: 10.1152/ajplung.00053.2002.
8
Identification and characterization of a novel interaction between pulmonary surfactant protein D and decorin.
J Biol Chem. 2003 Jul 11;278(28):25678-87. doi: 10.1074/jbc.M210186200. Epub 2003 May 2.

引用本文的文献

1
The Immune Modulatory Role of Surfactants in Infection.
J Inflamm Res. 2025 Feb 26;18:2909-2922. doi: 10.2147/JIR.S507526. eCollection 2025.
2
The Role of Pulmonary Collectins, Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D) in Cancer.
Cancers (Basel). 2024 Sep 10;16(18):3116. doi: 10.3390/cancers16183116.
4
Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia.
BMC Pulm Med. 2022 Sep 1;22(1):331. doi: 10.1186/s12890-022-02127-3.
6
Genetic disorders of the surfactant system: focus on adult disease.
Eur Respir Rev. 2021 Feb 16;30(159). doi: 10.1183/16000617.0085-2020. Print 2021 Mar 31.
7
Role of Surfactant Protein D in Experimental Otitis Media.
J Innate Immun. 2021;13(4):197-210. doi: 10.1159/000513605. Epub 2021 Feb 8.
9
Characteristics of surfactant proteins in tumorigenic and inflammatory lung lesions in rodents.
J Toxicol Pathol. 2018 Oct;31(4):231-240. doi: 10.1293/tox.2018-0025. Epub 2018 Jun 2.

本文引用的文献

2
Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.
Oncoimmunology. 2016 Jan 13;5(5):e1127493. doi: 10.1080/2162402X.2015.1127493. eCollection 2016 May.
3
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.
Hum Mol Genet. 2016 Apr 15;25(8):1457-67. doi: 10.1093/hmg/ddw014. Epub 2016 Jan 19.
4
Genetic variation in SP-A2 leads to differential binding to Mycoplasma pneumoniae membranes and regulation of host responses.
J Immunol. 2015 Jun 15;194(12):6123-32. doi: 10.4049/jimmunol.1500104. Epub 2015 May 8.
5
A structural perspective on the regulation of the epidermal growth factor receptor.
Annu Rev Biochem. 2015;84:739-64. doi: 10.1146/annurev-biochem-060614-034402. Epub 2015 Jan 26.
6
Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.
Oncogene. 2015 Feb 12;34(7):838-45. doi: 10.1038/onc.2014.20. Epub 2014 Mar 10.
7
Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.
J Biol Chem. 2013 Nov 15;288(46):32910-21. doi: 10.1074/jbc.M113.491902. Epub 2013 Oct 4.
8
Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.
Am J Pathol. 2013 May;182(5):1843-53. doi: 10.1016/j.ajpath.2013.01.030. Epub 2013 Mar 14.
9
Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome.
PLoS One. 2012;7(12):e51050. doi: 10.1371/journal.pone.0051050. Epub 2012 Dec 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验